MedTrace Logo

The Analysis of Immuno-Nutrition Index in Advanced Gastric Cancer Receiving Preoperative Treatments

NCT03493880 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2018-04-11

No results posted yet for this study

Summary

Based on multiple studies, the immune (systemic inflammation) and nutrition index were correlated with short- and long-term prognosis for gastric cancer. With the increasing application of preoperative treatments (chemotherapy and chemoradiotherapy), the issues concerning how are the immuno-nutrition index be altered under the effects of perioperative treatments and what are the clinical values of these index should be clarified.

Conditions

  • Gastric Cancer
  • Neoadjuvant Chemotherapy
  • Neoadjuvant Chemoradiotherapy
  • Systemic Inflammatory Response Syndrome (SIRS)
  • Nutrition Aspect of Cancer

Sponsors & Collaborators

  • Peking University

    lead OTHER

Principal Investigators

  • Jiafu Ji, M.D., Ph.D. · Peking University Cancer Hospital & Institute

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-01
Primary Completion
2020-09-01
Completion
2025-09-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03493880 on ClinicalTrials.gov